Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloid leukemia acute | D015470 | — | C92.0 | 4 | 9 | 2 | — | 1 | 15 |
Myelodysplastic syndromes | D009190 | — | D46 | 4 | 7 | 2 | — | — | 11 |
Leukemia | D007938 | — | C95 | 6 | 2 | 2 | — | — | 9 |
Megakaryoblastic leukemia acute | D007947 | — | C94.2 | 4 | 5 | 1 | — | — | 9 |
Monocytic leukemia acute | D007948 | — | — | 4 | 5 | 1 | — | — | 9 |
Myelomonocytic leukemia acute | D015479 | — | C92.5 | 4 | 5 | 1 | — | — | 9 |
Erythroblastic leukemia acute | D004915 | EFO_1001257 | C94.0 | 4 | 5 | 1 | — | — | 9 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | 3 | 1 | — | — | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | 10 | — | — | — | 10 |
Glioblastoma | D005909 | EFO_0000515 | — | 4 | 4 | — | — | — | 6 |
Myeloid leukemia | D007951 | — | C92 | 3 | 4 | — | — | — | 6 |
Multiple myeloma | D009101 | — | C90.0 | 3 | 3 | — | — | — | 4 |
Gliosarcoma | D018316 | — | — | 3 | 2 | — | — | — | 4 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 3 | 3 | — | — | — | 4 |
Basophilic leukemia acute | D015471 | — | C94.8 | 2 | 2 | — | — | — | 3 |
Eosinophilic leukemia acute | D015472 | — | — | 2 | 2 | — | — | — | 3 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | — | 3 | — | — | — | 3 |
Medulloblastoma | D008527 | — | — | — | 3 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 7 | — | — | — | — | 7 |
Blast crisis | D001752 | — | — | 1 | — | — | — | — | 1 |
Myeloproliferative disorders | D009196 | — | D47.1 | 1 | — | — | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | 1 | — | — | — | — | 1 |
Plasma cell neoplasms | D054219 | — | — | 1 | — | — | — | — | 1 |
Refractory anemia | D000753 | — | D46.4 | 1 | — | — | — | — | 1 |
Drug common name | Tipifarnib |
INN | tipifarnib |
Description | Tipifarnib is a quinolone that is 1-methylquinolin-2-one which carries a 3-chlorophenyl and an amino(4-chlorophenyl)(1-methyl-imidazol-5-yl)methyl groups at the 4 and 6 positions, respectively (the R-isomer). It has a role as an antineoplastic agent, an EC 2.5.1.58 (protein farnesyltransferase) inhibitor and an apoptosis inducer. It is a quinolone, a member of monochlorobenzenes, a member of imidazoles and a primary amino compound. |
Classification | Small molecule |
Drug class | farnesyl transferase inhibitor |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2c(c1)c(-c1cccc(Cl)c1)cc(=O)n2C |
PDB | — |
CAS-ID | 192185-72-1 |
RxCUI | — |
ChEMBL ID | CHEMBL289228 |
ChEBI ID | — |
PubChem CID | 159324 |
DrugBank | DB04960 |
UNII ID | MAT637500A (ChemIDplus, GSRS) |